Schwabe Pharmaceuticals Underlines Its Commitment to Research and Development With a Symposium on the Latest Study Results in the CNS field at the ECNP (European College of Neuropsychopharmacology) in Barcelona
10/17/2013 10:06:45 AM
BARCELONA, Spain--(BUSINESS WIRE)--'Expanding frontiers in the treatment of CNS diseases' was the promising and ambitious title of Schwabe’s symposium on the occasion of the 26th ECNP congress in Barcelona. Professor Siegfried Kasper (Medical University Vienna, Department of Biological Psychiatry and Psychotherapy), a well-known and equally well-respected psychiatrist, chaired the Monday afternoon event. The Symposium attracted a professional audience of medical experts from all fields of psychiatry and neurology to listen to and discuss the latest study results of Schwabe’s Ginkgo biloba extract EGb 761®, Lavender essential oil Silexan® and Rhodiola rosea extract WS® 1375.
Help employers find you! Check out all the jobs and post your resume.
comments powered by